Sudo Biosciences
- Biotech or pharma, therapeutic R&D
Sudo is a clinical stage biotech company developing a pipeline of differentiated TYK2 pseudokinase inhibitors for a range of autoimmune indications.
June 16-19, 2025
Boston Convention & Exhibition Center
Sudo is a clinical stage biotech company developing a pipeline of differentiated TYK2 pseudokinase inhibitors for a range of autoimmune indications.